134 related articles for article (PubMed ID: 6255652)
21. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer.
Ettinger DS
Semin Oncol; 2001 Apr; 28(2 Suppl 4):27-9. PubMed ID: 11479894
[TBL] [Abstract][Full Text] [Related]
22. Treatment of extensive small cell lung cancer.
Davies AM; Lara PN; Lau DH; Gandara DR
Hematol Oncol Clin North Am; 2004 Apr; 18(2):373-85. PubMed ID: 15094177
[No Abstract] [Full Text] [Related]
23. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Joss RA; Brunner KW; Goldhirsch A
Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
[No Abstract] [Full Text] [Related]
24. Evaluating new drugs as first treatment in patients with small-cell carcinoma: guidelines for an ethical approach with implications for other chemotherapy-sensitive tumors.
Cullen MH; Hilton C; Stuart NS
J Clin Oncol; 1988 Aug; 6(8):1356-7. PubMed ID: 2842466
[No Abstract] [Full Text] [Related]
25. [Current outcomes and future directions in the chemotherapy of lung cancer].
Hara N
Fukuoka Igaku Zasshi; 1993 Sep; 84(9):389-94. PubMed ID: 8225159
[No Abstract] [Full Text] [Related]
26. Kinetically scheduled therapy for extensive small-cell lung cancer.
Clamon GH; McFadden DB; Weisenfeld M; Bell S
Cancer Clin Trials; 1981; 4(2):159-62. PubMed ID: 6265111
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Creech RH; Stanley K; Vogl SE; Ettinger DS; Bonomi PD; Salazar O
Cancer Treat Rep; 1982 Jun; 66(6):1417-9. PubMed ID: 6282460
[TBL] [Abstract][Full Text] [Related]
28. The use of experimental systems in the therapeutic research of small cell lung cancer.
Carney DN; Gazdar AF; Minna JD
Pathobiol Annu; 1982; 12():115-36. PubMed ID: 6131405
[No Abstract] [Full Text] [Related]
29. [Combined chemotherapy and radiotherapy of small cell carcinoma of the lung].
Arjane G; Guay JP
Union Med Can; 1981 Apr; 110(4):358-60. PubMed ID: 6264654
[No Abstract] [Full Text] [Related]
30. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a Phase II clinical trial.
Altundag O; Altundag K; Boruban C; Silay YS; Turen S
Cancer; 2005 Nov; 104(9):2033-4; author reply 2034. PubMed ID: 16161057
[No Abstract] [Full Text] [Related]
31. A case of mediastinal emphysema in a 80-year old male.
Khan S
Lung Cancer; 2006 Mar; 51(3):391-2. PubMed ID: 16413946
[No Abstract] [Full Text] [Related]
32. [Polyamines in the evaluation of the effectiveness of cancer patient treatment].
Bassalyk LS; Nemtsova MP; Merabishvili NV; Tevzadze TA; Korbukh IA
Vestn Akad Med Nauk SSSR; 1982; (3):57-61. PubMed ID: 6283759
[No Abstract] [Full Text] [Related]
33. [Symptoms of depression in cancer patients undergoing chemotherapy].
Middelboe T; Ovesen LF; Mortensen EL; Bech P
Ugeskr Laeger; 1995 Mar; 157(13):1849-52. PubMed ID: 7725562
[TBL] [Abstract][Full Text] [Related]
34. Waging war on lung cancer.
Brown E
FDA Consum; 1999; 33(3):7-8, 10-1. PubMed ID: 10443183
[No Abstract] [Full Text] [Related]
35. Treatment of recurrent small cell lung cancer.
Davies AM; Evans WK; Mackay JA; Shepherd FA
Hematol Oncol Clin North Am; 2004 Apr; 18(2):387-416. PubMed ID: 15094178
[No Abstract] [Full Text] [Related]
36. Lambert-eaton myasthenic syndrome: a case report and review of the literature.
Lin JT; Lachmann E
J Womens Health (Larchmt); 2002 Dec; 11(10):849-55. PubMed ID: 12626085
[TBL] [Abstract][Full Text] [Related]
37. Foreword--new directions for topotecan in lung cancer treatment.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():1-3. PubMed ID: 15616144
[No Abstract] [Full Text] [Related]
38. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R
Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700
[TBL] [Abstract][Full Text] [Related]
39. [The role of surgery in the treatment of small cell lung cancer].
Puma F; Urbani M; Santoprete S; Ricci F; Sanguinetti A; Vinci D; Ottavi P; Porcaro G; Daddi G
Minerva Endocrinol; 2001 Dec; 26(4):247-53. PubMed ID: 11782710
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
